Tregs as Medicine:
Tolerance and InTolerance Seminar
Friday, September 26, 2025 | 9:00 am – 6:00 pm | The Westin Hotel, Meguro, Tokyo
The inaugural Tregs as Medicine: Tolerance and InTolerance Seminar will bring together top scientists and industry leaders to explore how regulatory T cells and tolerance mechanisms are shaping the future of biologics and vaccines. This free event will highlight emerging research and real-world applications of Tregs in autoimmunity, cancer, and infectious disease, with a focus on their role in pathogenesis, therapeutic development, and immune modulation.
The agenda will feature a keynote presentation from Dr. Shimon Sakaguchi, a world-renowned expert on immune tolerance, who will speak on the therapeutic potential of targeting Tregs in cancer and autoimmune disease. Attendees will also gain insights into advances in immune profiling, antigen processing, and immune camouflage, and how these approaches are redefining tolerance pathways in translational medicine.
With speakers from leading academic institutions, global pharmaceutical companies, and pioneering biotech startups, this seminar offers a unique opportunity to connect across disciplines and explore the evolving science behind immune tolerance.
Please note: This is an in-person event with no options for virtual attendance
Organizing Committee:
Annie De Groot, MD Founder & CSO, EpiVax Inc.
Cevayir Coban, PhD Institute of Medical Science, Department of Microbiology and Immunology, Division of Malaria Immunology, University of Tokyo
Vibha Jawa, PhD Chief Scientific Officer, EpiVax, Inc.
Amy Rosenberg, MD Senior Director, Regulatory Affairs, Regeneron Inc.
David W. Scott, PhD Professor of Medicine Emeritus, Uniformed Services University of the Health Sciences
Jochem Gokemeijer, PhD Distinguished Scientist, Biologics, Johnson & Johnson
Confirmed Speakers:
Ken Ishii, MD PhD Director, International Vaccine Design Center. Professor, Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo
Shimon Sakaguchi, MD PhD Principal Investigator, Osaka University
Alessandra Franco, MD PhD Adjunct Professor, Pediatrics, University of San Diego
Laura Santambrogio, MD PhD Associate Director Precision Immunology, Weill Cornell Medicine
Olaf Rötzschke, PhD Senior Principal Investigator, A*STAR Singapore
Piotr Trzonkowski, MD PhD CEO, PolTREG
… With many more to be announced soon! Register now to be the first to receive updates.
And join us for the 17th annual Westin Immunogenicity Seminar on Thursday, September 25! More Information and Register |
